Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaina F Bruce

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Treatment Options in Oncology|February 15, 2022
The Use of Targeted Agents in the Treatment of Gynecologic CancersShaina F Bruce, Matthew A Powell
Gynecologic Oncology Reports|June 15, 2026
Impact of preoperative frailty assessment on peri-operative complications and cancer related outcomes in advanced stage endometrial cancerChristine I Cho, Anne-Laure Strong, Brooke Arner, et al.
Gynecologic Oncology|March 18, 2018
Implementation of an abdominal closure bundle to reduce surgical site infection in patients on a gynecologic oncology service undergoing exploratory laparotomyShaina F Bruce, Danielle N Carr, Elizabeth R Burton, et al.
Obstetrics and Gynecology|August 13, 2019
Disparities Among Cervical Cancer Patients Receiving BrachytherapyShaina F Bruce, Tanvi V Joshi, Inna Chervoneva, et al.
Gynecologic Oncology Reports|May 26, 2021
Implementation of an enhanced recovery protocol in gynecologic oncologyTanvi V Joshi, Shaina F Bruce, Rod Grim, et al.
Gynecologic Oncology|April 1, 2023
HER2+ endometrioid endometrial cancer possesses distinct molecular and immunologic features associated with a more active immune microenvironment and worse prognosisShaina F Bruce, Sharon Wu, Jennifer R Ribeiro, et al.
Gynecologic Oncology Reports|January 13, 2022
Impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology careShaina F Bruce, Bridget Huysman, Jinai Bharucha, et al.
Cancers|December 10, 2021
Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous CancerMichael D Toboni, Elena Lomonosova, Shaina F Bruce, et al.
Molecular Cancer Therapeutics|May 19, 2022
GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell GlycolysisShaina F Bruce, Kevin Cho, Hollie Noia, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Treatment Options in Oncology|February 15, 2022
The Use of Targeted Agents in the Treatment of Gynecologic CancersShaina F Bruce, Matthew A Powell
Gynecologic Oncology Reports|June 15, 2026
Impact of preoperative frailty assessment on peri-operative complications and cancer related outcomes in advanced stage endometrial cancerChristine I Cho, Anne-Laure Strong, Brooke Arner, et al.
Gynecologic Oncology|March 18, 2018
Implementation of an abdominal closure bundle to reduce surgical site infection in patients on a gynecologic oncology service undergoing exploratory laparotomyShaina F Bruce, Danielle N Carr, Elizabeth R Burton, et al.
Obstetrics and Gynecology|August 13, 2019
Disparities Among Cervical Cancer Patients Receiving BrachytherapyShaina F Bruce, Tanvi V Joshi, Inna Chervoneva, et al.
Gynecologic Oncology Reports|May 26, 2021
Implementation of an enhanced recovery protocol in gynecologic oncologyTanvi V Joshi, Shaina F Bruce, Rod Grim, et al.
Gynecologic Oncology|April 1, 2023
HER2+ endometrioid endometrial cancer possesses distinct molecular and immunologic features associated with a more active immune microenvironment and worse prognosisShaina F Bruce, Sharon Wu, Jennifer R Ribeiro, et al.
Gynecologic Oncology Reports|January 13, 2022
Impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology careShaina F Bruce, Bridget Huysman, Jinai Bharucha, et al.
Cancers|December 10, 2021
Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous CancerMichael D Toboni, Elena Lomonosova, Shaina F Bruce, et al.
Molecular Cancer Therapeutics|May 19, 2022
GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell GlycolysisShaina F Bruce, Kevin Cho, Hollie Noia, et al.
Pageof 1